Validation of the Chinese drug hypersensitivity quality of life questionnaire: Role of delabeling.

Hugo W F MakElsie T S ChanJackie S H YimElaine LeeDorothy L Y LamValerie ChiangPhilip H Li

Published in: Asia Pacific allergy (2023)

The Chinese DrHy-Q is reliable and valid for HRQoL assessment. PA delabeling significantly benefits patients' HRQoL. Future larger-scale studies are warranted to corroborate our findings.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
drug induced
cross sectional
emergency department
current status
patient reported outcomes
adverse drug
psychometric properties